Catalyst Wire Dossier Catalyst Wire Dossier

Amlodipine besylate and candesartan cilexetil combination

· HK inno.N Corporation
Drug timelines are a Plus or Pro feature.

2 regulatory and trial events tracked for Amlodipine besylate and candesartan cilexetil combination, covering 2023-05-06 to 2023-05-06. Get the full timeline:

Most recent: Clinical Trial Update: A Study to Evaluate the Efficacy and Safety of Amlodipine Besylate and Candesartan Cilexetil in Essential Hypertension Patient Who Are Not Adequately Controlled With Candesartan Cilexetil Monotherapy [Phase 3]

See pricing